Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

New gastric antisecretory agents patented by Byk Gulden

Nov. 27, 2000

Roche's new antiinflammatory agents inhibit alpha4 integrin binding

Nov. 27, 2000

Novel class of H3 antagonists identified through Novo Nordisk/Boehringer Ingelheim collaboration

Nov. 27, 2000

Novel cyclic tyrosine kinase inhibitors reported by BMS scientists

Nov. 27, 2000

R&D at Sanofi-Synthelabo leads to identification of potent PDE5 inhibitors

Nov. 27, 2000

Modulators of metabotropic glutamate receptors disclosed by Roche

Nov. 27, 2000

Novel pharmaceutical compositions prepared for rosiglitazone

Nov. 27, 2000

Selective delta opioid receptor agonists in the SB pipeline

Nov. 24, 2000

Merck's new integrin receptor antagonists for thrombosis, osteoporosis, atherosclerosis

Nov. 24, 2000

New erythromycin-based antimicrobial agents identified at Pliva

Nov. 24, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...